{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,22]],"date-time":"2026-07-22T04:46:36Z","timestamp":1784695596255,"version":"3.55.0"},"reference-count":13,"publisher":"Massachusetts Medical Society","issue":"7","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["N Engl J Med"],"published-print":{"date-parts":[[2021,8,12]]},"DOI":"10.1056\/nejme2110605","type":"journal-article","created":{"date-parts":[[2021,7,21]],"date-time":"2021-07-21T21:01:24Z","timestamp":1626901284000},"page":"650-651","source":"Crossref","is-referenced-by-count":67,"title":["Vaccine Effectiveness Studies in the Field"],"prefix":"10.1056","volume":"385","author":[{"given":"Stephen J.W.","family":"Evans","sequence":"first","affiliation":[{"name":"From the London School of Hygiene and Tropical Medicine, London."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicholas P.","family":"Jewell","sequence":"additional","affiliation":[{"name":"From the London School of Hygiene and Tropical Medicine, London."}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"150","reference":[{"key":"e_1_3_4_2_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(21)00677-2"},{"key":"e_1_3_4_3_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa2108891"},{"key":"e_1_3_4_4_2","doi-asserted-by":"publisher","DOI":"10.1097\/EDE.0000000000001116"},{"key":"e_1_3_4_5_2","doi-asserted-by":"crossref","unstructured":"Skowronski DM Setayeshgar S Zou M et al. Single-dose mRNA vaccine effectiveness against SARS-CoV-2 including P.1 and B.1.1.7 variants: a test-negative design in adults 70 years and older in British Columbia Canada. June 9 2021 (https:\/\/www.medrxiv.org\/content\/10.1101\/2021.06.07.21258332v1). preprint.","DOI":"10.1093\/cid\/ciab616"},{"key":"e_1_3_4_6_2","unstructured":"Hitchings MDT Ranzani OT Torres MSS et al. Effectiveness of CoronaVac among healthcare workers in the setting of high SARS-CoV-2 gamma variant transmission in Manaus Brazil: a test-negative case-control study. June 24 2021 (https:\/\/www.medrxiv.org\/content\/10.1101\/2021.04.07.21255081v4.full). preprint."},{"key":"e_1_3_4_7_2","article-title":"AZD1222-induced neutralising antibody activity against SARS-CoV-2 Delta VOC.","author":"Wall EC","year":"2021","unstructured":"Wall EC, Wu M, Harvey R, et al. AZD1222-induced neutralising antibody activity against SARS-CoV-2 Delta VOC. Lancet 2021 June 28 (Epub ahead of print).34197809","journal-title":"Lancet"},{"key":"e_1_3_4_8_2","doi-asserted-by":"publisher","DOI":"10.1097\/EDE.0000000000001366"},{"key":"e_1_3_4_9_2","doi-asserted-by":"crossref","unstructured":"Choi A Koch M Wu K et al. Serum neutralizing activity of mRNA-1273 against SARS-CoV-2 variants. June 28 2021 (https:\/\/www.biorxiv.org\/content\/10.1101\/2021.06.28.449914v1). preprint.","DOI":"10.1101\/2021.06.28.449914"},{"key":"e_1_3_4_10_2","doi-asserted-by":"crossref","unstructured":"Jongeneelen M Kaszas K Veldman D et al. Ad26.COV2.S elicited neutralizing activity against Delta and other SARS-CoV-2 variants of concern. July 1 2021 (https:\/\/www.biorxiv.org\/content\/10.1101\/2021.07.01.450707v1). preprint.","DOI":"10.1101\/2021.07.01.450707"},{"key":"e_1_3_4_11_2","doi-asserted-by":"publisher","DOI":"10.1038\/s41586-021-03738-2"},{"key":"e_1_3_4_12_2","unstructured":"Nasreen S He S Chung H et al. Effectiveness of COVID-19 vaccines against variants of concern Canada. July 3 2021 (https:\/\/www.medrxiv.org\/content\/10.1101\/2021.06.28.21259420v1). preprint."},{"key":"e_1_3_4_13_2","unstructured":"Public Health England. Direct and indirect impact of the vaccination programme on COVID-19 infections and mortality. June 28 2021 (https:\/\/assets.publishing.service.gov.uk\/government\/uploads\/system\/uploads\/attachment_data\/file\/997495\/Impact_of_COVID-19_vaccine_on_infection_and_mortality.pdf)."},{"key":"e_1_3_4_14_2","doi-asserted-by":"crossref","unstructured":"Galvani A Moghadas SM Schneider EC. Deaths and hospitalizations averted by rapid U.S. vaccination rollout. The Commonwealth Fund Issue Briefs. July 7 2021 (https:\/\/www.commonwealthfund.org\/publications\/issue-briefs\/2021\/jul\/deaths-and-hospitalizations-averted-rapid-us-vaccination-rollout).","DOI":"10.1101\/2021.07.07.21260156"}],"container-title":["New England Journal of Medicine"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.nejm.org\/doi\/pdf\/10.1056\/NEJMe2110605","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,6,11]],"date-time":"2025-06-11T23:30:14Z","timestamp":1749684614000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.nejm.org\/doi\/10.1056\/NEJMe2110605"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,8,12]]},"references-count":13,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2021,8,12]]}},"alternative-id":["10.1056\/NEJMe2110605"],"URL":"https:\/\/doi.org\/10.1056\/nejme2110605","relation":{},"ISSN":["0028-4793","1533-4406"],"issn-type":[{"value":"0028-4793","type":"print"},{"value":"1533-4406","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,8,12]]}}}